pharma news today glp-1 obesity What is the pipeline for future medications for obesity? GLP-1 RAs gain popularity as

As predicted by trRosetta, the fusion of HSA-binding DARPin to GLP-1 using a rigid helical linker does not alter the tertiary structure of the fusion partner, and each moiety of the fusion proteins will most likely retain their conformational properties and relevant biological functions as the native protein

As soon as I squatted down, it would make cracking sounds

For the latest news, weather, sports, and streaming video, head to The Hill.

Patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use these medications

uncertainties regarding the impact of COVID-19 on Pfizers business, operations and financial results

If you're considering options for weight or metabolic health, talk with your healthcare provider